| PEACE V–Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): A study protocol for a randomized controlled phase II trial A De Bruycker, A Spiessens, P Dirix, N Koutsouvelis, I Semac, ... BMC cancer 20, 1-12, 2020 | 67 | 2020 |
| Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation B Bojaxhiu, AJ Templeton, O Elicin, M Shelan, K Zaugg, M Walser, ... Radiation oncology 13, 1-9, 2018 | 61 | 2018 |
| Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity M Shelan, Y Abo-Madyan, G Welzel, C Bolenz, J Kosakowski, N Behnam, ... Radiation Oncology 8, 1-8, 2013 | 42 | 2013 |
| Long-term functional outcome after laryngeal cancer treatment L Anschuetz, M Shelan, M Dematté, AD Schubert, R Giger, O Elicin Radiation oncology 14, 1-8, 2019 | 41 | 2019 |
| Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus BA Jereczek-Fossa, G Marvaso, M Zaffaroni, SG Gugliandolo, D Zerini, ... Cancer treatment reviews 98, 102206, 2021 | 34 | 2021 |
| T1-2 glottic cancer treated with radiotherapy and/or surgery. M Shelan, L Anschuetz, AD Schubert, B Bojaxhiu, A Dal Pra, ... Strahlentherapie und Onkologie 193 (12), 995-1004, 2017 | 28 | 2017 |
| The multicenter, randomized, phase 2 PEACE V-STORM trial: defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases T Zilli, P Dirix, R Heikkilä, N Liefhooghe, S Siva, A Gomez-Iturriaga, ... European urology focus 7 (2), 241-244, 2021 | 20 | 2021 |
| Predicting factors for oncological and functional outcome in hypopharyngeal cancer M Visini, R Giger, M Shelan, O Elicin, L Anschuetz The Laryngoscope 131 (5), E1543-E1549, 2021 | 19 | 2021 |
| Disease control with delayed salvage radiotherapy for macroscopic local recurrence following radical prostatectomy M Shelan, S Odermatt, B Bojaxhiu, DP Nguyen, GN Thalmann, ... Frontiers in oncology 9, 12, 2019 | 17 | 2019 |
| The impact of delivery daytime and seasonality of radiotherapy for head and neck cancer on toxicity burden EK Brolese, N Cihoric, B Bojaxhiu, B Sermaxhaj, DH Schanne, E Mathier, ... Radiotherapy and oncology 158, 162-166, 2021 | 14 | 2021 |
| Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy for recurrent prostate cancer C Zamboglou, JC Peeken, A Janbain, S Katsahian, I Strouthos, ... JAMA Network Open 6 (5), e2314748-e2314748, 2023 | 11 | 2023 |
| Detection of local recurrence with 3-tesla MRI after radical prostatectomy: a useful method for radiation treatment planning? D Buergy, M Sertdemir, A Weidner, M Shelan, F Lohr, F Wenz, ... in vivo 32 (1), 125-131, 2018 | 11 | 2018 |
| Unplanned hospitalizations in patients with locoregionally advanced head and neck cancer treated with (chemo) radiotherapy with and without prophylactic percutaneous endoscopic … B Bojaxhiu, BK Shrestha, P Luterbacher, O Elicin, M Shelan, ... Radiation Oncology 15, 1-11, 2020 | 9 | 2020 |
| Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer–a retrospective study N Cihoric, A Tsikkinis, E Vlaskou Badra, M Glatzer, U Novak, A Scherz, ... Radiation oncology 12, 1-8, 2017 | 9 | 2017 |
| Salvage radiotherapy is effective in patients with PSMA-PET-negative biochemical recurrence-results of a retrospective study S Scharl, C Zamboglou, I Strouthos, A Farolfi, F Serani, H Lanzafame, ... Radiotherapy and Oncology 184, 109678, 2023 | 8 | 2023 |
| The prognostic impact of daytime and seasonality of radiotherapy on head and neck cancer O Elicin, EK Brolese, B Bojaxhiu, B Sermaxhaj, DH Schanne, E Mathier, ... Radiotherapy and oncology 158, 293-299, 2021 | 8 | 2021 |
| Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer—A Multicenter Study O Elicin, E Ermiş, C Oehler, DM Aebersold, F Caparrotti, F Zimmermann, ... Frontiers in oncology 9, 932, 2019 | 8 | 2019 |
| PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA< 0.2 ng/ml N Solomonidou, D Germanou, I Strouthos, E Karagiannis, A Farolfi, ... European journal of nuclear medicine and molecular imaging 50 (8), 2529-2536, 2023 | 6 | 2023 |
| Salvage stereotactic reirradiation for local recurrence in the prostatic bed after prostatectomy: A retrospective multicenter study P Archer, G Marvaso, B Detti, F Colombo, G Francolini, B Vandendorpe, ... European urology oncology 6 (3), 303-310, 2023 | 6 | 2023 |
| PEACE V—Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): acute toxicity of a randomized phase 2 trial P Ost, S Siva, S Brabrand, P Dirix, N Liefhooghe, FX Otte, ... European urology oncology, 2023 | 5 | 2023 |
